Related Experiment Videos
Naltrexone: a short-term treatment for opiate dependence
The American Journal of Drug and Alcohol Abuse
|January 1, 1981
Summary
Naltrexone, a narcotic antagonist, significantly decreased drug use in patients with opiate dependence. Despite high discontinuation rates, naltrexone shows promise as a short-term treatment option for reducing opiate and nonopiate drug use.
Area of Science:
- Pharmacology
- Addiction Medicine
- Clinical Psychology
Background:
- Opiate dependence is a significant public health issue requiring effective treatment options.
- Naltrexone is an opioid antagonist with potential for managing substance use disorders.
- Long-term treatment retention remains a challenge in addiction pharmacotherapy.
Purpose of the Study:
- To evaluate the effectiveness of naltrexone in reducing drug use among patients with opiate dependence.
- To identify factors influencing treatment retention during naltrexone therapy.
- To assess posttreatment outcomes in patients receiving naltrexone.
Main Methods:
- A 6-year study involving 242 patients treated with naltrexone.
- Assessment of drug use patterns (opiate and nonopiate) during and after treatment.
- Analysis of patient retention rates during induction and maintenance phases.
Main Results:
- Naltrexone treatment was associated with a significant reduction in both opiate and nonopiate drug use.
- A substantial number of patients discontinued naltrexone treatment prematurely.
- Posttreatment outcomes indicated potential benefits for some patients.
Conclusions:
- Naltrexone may serve as a valuable short-term treatment for individuals with opiate dependence.
- Strategies to improve patient retention are crucial for maximizing naltrexone's efficacy.
- Further research into optimizing naltrexone treatment protocols is warranted.